One example is the possible use of CFTR potentiators in the treatment of COPD, which has a compelling pre-clinical rationale (reviewed in ref. [9]) and has been the subject of early-phase clinical trials [166]. This evidence concerns the gene CFTR and chronic obstructive pulmonary disease.